L-isoleucine-supplemented Oral Rehydration Solution in the Treatment of Acute Diarrhoea in Children: A Randomized Controlled Trial
2011

L-isoleucine in Oral Rehydration Solution for Treating Diarrhoea in Children

Sample size: 50 publication Evidence: moderate

Author Information

Author(s): N.H. Alam, Raqib R., Ashraf H., Qadri F., Ahmed S., Zasloff M., Agerberth B., Salam M.A., Gyr N., Meier R.

Primary Institution: ICDDR,B, Dhaka, Bangladesh

Hypothesis

Does L-isoleucine added to oral rehydration salts reduce stool output and duration of acute diarrhoea in children while inducing antimicrobial peptides in the intestine?

Conclusion

L-isoleucine-supplemented ORS may help reduce stool output and ORS intake in children with acute watery diarrhoea.

Supporting Evidence

  • The study showed a significant reduction in stool output on day 3 for the L-isoleucine group.
  • ORS intake was significantly lower on day 1 in the L-isoleucine group.
  • No adverse effects were reported from the L-isoleucine treatment.

Takeaway

This study tested if adding a special ingredient called L-isoleucine to a drink for kids with diarrhoea could help them feel better faster. It seemed to help reduce how much they pooped and how much of the drink they needed.

Methodology

A double-blind randomized controlled trial with 50 male children aged 6-36 months, comparing L-isoleucine-added ORS to standard ORS.

Limitations

The study had a small sample size and did not assess bacterial/viral load in stool or the active form of antimicrobial peptides.

Participant Demographics

50 male children aged 6-36 months with acute diarrhoea and some dehydration.

Statistical Information

P-Value

p=0.035 for stool output on day 3; p=0.04 for ORS intake on day 1.

Confidence Interval

95% CI (-509, −20) for stool output; 95% CI (-288, −18) for ORS intake.

Statistical Significance

p<0.05

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication